Larvol Delta - CONGO-Safety-and-Bioactivity-of-AXT107-in-Subjects-With-Diabetic-Macular-Edema

gersizangitide (AXT107) - Asclepix

http://clinicaltrials.gov/ct2/show/NCT04697758

Jul 20, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next